|
| Press Releases |
|
 |
|
| Tuesday, April 14, 2026 |
|
|
Wellgistics Health 與 Kare PharmTech 成立合資企業，將服務範圍擴展至 20 萬名以上患者 |
| Wellgistics Health, Inc. (NASDAQ:WGRX) （「Wellgistics」或「本公司」），一家領先的醫療保健科技與藥品分銷公司，今日宣布與 Kare PharmTech 的全資子公司 Kare Rx Hub, LLC（「KareRx」）簽署最終合資協議。KareRx 是一家以人工智慧（AI）為驅動的數位樞紐，致力於支援零售藥房、遠距醫療及特殊藥品計畫。 more info >> |
|
|
Wellgistics Health 与 Kare PharmTech 成立合资企业，服务覆盖范围将扩展至 20 万余名患者 |
| Wellgistics Health, Inc. (NASDAQ:WGRX) （“Wellgistics”或“公司”），一家领先的医疗健康技术与药品分销公司，今日宣布已与Kare PharmTech的全资子公司Kare Rx Hub, LLC（“KareRx”）签署最终合资协议。KareRx是一家由人工智能（AI）驱动的数字枢纽，致力于支持零售药房、远程医疗及专科药品项目。 more info >> |
|
|
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives |
| Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs. more info >> |
|
| Monday, March 23, 2026 |
|
|
Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書，以評估收購 Neuritek Therapeutics, Inc. 的可能性；該公司致力於開發治療神經系統及精神疾病的創新療法 |
| Wellgistics Health, Inc.（「Wellgistics」或「本公司」）（納斯達克代碼：WGRX）今日宣布，已簽署一份非獨家且不具約束力的意向書（「LOI」），以評估潛在收購專注於神經科學研究的機構Neuritek Therapeutics。 more info >> |
|
|
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法 |
| Wellgistics Health, Inc.（“Wellgistics”或“公司”）（纳斯达克代码：WGRX）今日宣布，已签署一份非独家、非约束性的意向书（“LOI”），旨在评估潜在收购专注于神经科学研究的机构Neuritek Therapeutics。 more info >> |
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders |
| Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Apr 14, 2026 22:00: JST
|
|
|
P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026
Apr 14, 2026 22:00: JST
|
|
|
Datavault AI 與 AgSensor Solutions 宣布建立諮詢合作夥伴關係，將高價值農業數據資產代幣化
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Datavault AI 与 AgSensor Solutions 宣布建立咨询合作伙伴关系，旨在将高价值农业数据资产代币化
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Apr 14, 2026 21:00 HKT/SGT
|
|
|
寶潔與 OMP 於 2026 年 Gartner 供應鏈研討會暨博覽會（Gartner Supply Chain Symposium/Xpo 2026）展示邁向自主化、以決策為中心的規劃之路
Apr 14, 2026 21:00 HKT/SGT
|
|
|
宝洁与OMP在2026年Gartner供应链研讨会暨博览会（Gartner Supply Chain Symposium/Xpo 2026）上展示通往自主、以决策为中心的规划之路
Apr 14, 2026 21:00 HKT/SGT
|
|
|
P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Apr 14, 2026 20:05: JST
|
|
|
HKTDC launches GoGlobal Connect to help mainland firms go global via Hong Kong
Apr 14, 2026 19:40: JST
|
|
|
Wellgistics Health 與 Kare PharmTech 成立合資企業，將服務範圍擴展至 20 萬名以上患者
Apr 14, 2026 19:05 HKT/SGT
|
|
|
Wellgistics Health 与 Kare PharmTech 成立合资企业，服务覆盖范围将扩展至 20 万余名患者
Apr 14, 2026 19:05 HKT/SGT
|
|
|
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Apr 14, 2026 19:05 HKT/SGT
|
|
|
全球運動品牌 U.S. Polo Assn. 推出《Field X Fashion》第三期
Apr 14, 2026 19:00 HKT/SGT
|
|
|
全球运动品牌U.S. Polo Assn. 推出《Field X Fashion》第三期
Apr 14, 2026 19:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
